The Dynamics of Clinical Parameters in Romanian COPD Patients Treated With Inhaled Corticosteroid/Long-Acting Beta Agonist Regimens in a Real-World Study (RELIEF)

Florin Mihaltan; Dragos Ungureanu; Gabriela Teodorescu

doi:10.1016/j.chest.2017.08.830

The Dynamics of Clinical Parameters in Romanian COPD Patients Treated With Inhaled Corticosteroid/Long-Acting Beta Agonist Regimens in a Real-World Study (RELIEF)

CHEST Journal ◽

10.1016/j.chest.2017.08.830 ◽

2017 ◽

Vol 152 (4) ◽

pp. A799

Author(s):

Florin Mihaltan ◽

Dragos Ungureanu ◽

Gabriela Teodorescu

Keyword(s):

Real World ◽

Beta Agonist ◽

Clinical Parameters ◽

Inhaled Corticosteroid ◽

Copd Patients ◽

Long Acting

Download Full-text

Switching to maintenance and reliever inhaled corticosteroid/long acting beta agonist: a real-world pilot evaluation in a regional paediatric difficult asthma clinic

10.1183/13993003.congress-2020.583 ◽

2020 ◽

Author(s):

May Al-moasseb ◽

Victoria Worrall ◽

Philip Lawrence ◽

Ian Sinha

Keyword(s):

Real World ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Difficult Asthma ◽

Long Acting

Download Full-text

Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence

Scientific Reports ◽

10.1038/s41598-019-48355-2 ◽

2019 ◽

Vol 9 (1) ◽

Author(s):

Ju-Hee Park ◽

Yunjung Kim ◽

Seongmi Choi ◽

Eun Jin Jang ◽

Jimin Kim ◽

...

Keyword(s):

Emergency Room ◽

Real World ◽

Emergency Room Visit ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Delivery Device ◽

Airway Diseases ◽

Real World Evidence ◽

Long Acting ◽

Chronic Airway

Download Full-text

Real-world Comparative Effectiveness Of Extrafine Hydrofluoroalkane-beclomethasone (EF HFA-BDP) Versus Inhaled Corticosteroid (ICS) / Long-acting Beta-agonist (LABA) Therapy In Pediatric Asthma

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2012.01.019 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB368

Author(s):

D.B. Price ◽

R. Martin ◽

P. Dorinsky ◽

A.J. Lee ◽

A. Burden ◽

...

Keyword(s):

Real World ◽

Comparative Effectiveness ◽

Pediatric Asthma ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Long Acting

Download Full-text

PRS46 OFF-LABEL PRESCRIBING OF INHALED CORTICOSTEROID/ LONG ACTING BETA-AGONIST COMBINATION PRODUCTS IN COPD PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)74508-3 ◽

2009 ◽

Vol 12 (7) ◽

pp. A307

Author(s):

U Rigney ◽

C Emmas ◽

J Morais

Keyword(s):

Beta Agonist ◽

Inhaled Corticosteroid ◽

Off Label ◽

Copd Patients ◽

Long Acting

Download Full-text

Real-world Effectiveness Of Asthma Step-up Options: Matched Comparison Of Extrafine Hydrofluoroalkane-beclometasone AND Inhaled Corticosteroid / Long-Acting Beta-Agonist

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2011.12.723 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB61

Author(s):

D.B. Price ◽

R. Martin ◽

N. Barnes ◽

N. Roche ◽

A.J. Lee ◽

...

Keyword(s):

Real World ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Long Acting ◽

Matched Comparison

Download Full-text

Real-world comparative effectiveness of extrafine hydrofluoroalkane-beclomethasone (EF HFA-BDP) versus fluticasone propionate (FP) and inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA) as step-up therapy in paediatric asthma

Paediatric Respiratory Reviews ◽

10.1016/s1526-0542(13)70137-4 ◽

2013 ◽

Vol 14 ◽

pp. S78 ◽

Cited By ~ 1

Author(s):

W.M.C. van Aalderen ◽

J. Grigg ◽

G. Colice ◽

R.J. Martin ◽

N. Roche ◽

...

Keyword(s):

Fluticasone Propionate ◽

Real World ◽

Comparative Effectiveness ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Paediatric Asthma ◽

Long Acting

Download Full-text

Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous Year

Clinical Drug Investigation ◽

10.1007/s40261-021-01067-w ◽

2021 ◽

Author(s):

Pier Paolo Mangia ◽

Ottavio Gallo ◽

Daniela Ritrovato ◽

Lorenzo Pradelli

Keyword(s):

Cost Utility ◽

Beta Agonist ◽

Fixed Dose ◽

High Dose ◽

Inhaled Corticosteroid ◽

Utility Analysis ◽

Glycopyrronium Bromide ◽

Asthma Exacerbations ◽

Dose Combination ◽

Long Acting

Download Full-text

In adults with mild persistent asthma, is as-needed use of a combined inhaled corticosteroid plus long-acting beta-agonist as effective as scheduled use of an inhaled corticosteroid alone in preventing asthma exacerbations?

Evidence-Based Practice ◽

10.1097/ebp.0000000000001292 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Vishalakshi Sundaram ◽

Linda Wei Zhang ◽

Paige Gwynn

Keyword(s):

Persistent Asthma ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Asthma Exacerbations ◽

Mild Persistent Asthma ◽

Long Acting

Download Full-text

Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis

Respirology ◽

10.1111/resp.12603 ◽

2015 ◽

Vol 20 (8) ◽

pp. 1153-1159 ◽

Cited By ~ 19

Author(s):

Nobuyuki Horita ◽

Naoki Miyazawa ◽

Koji Tomaru ◽

Miyo Inoue ◽

Takeshi Kaneko

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Muscarinic Antagonist ◽

Long Acting

Download Full-text

Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma

The Lancet Child & Adolescent Health ◽

10.1016/s2352-4642(21)00268-6 ◽

2021 ◽

Cited By ~ 1

Author(s):

Victor E Ortega ◽

Michelle Daya ◽

Stanley J Szefler ◽

Eugene R Bleecker ◽

Vernon M Chinchilli ◽

...

Keyword(s):

Randomised Controlled Trials ◽

African Descent ◽

Beta Agonist ◽

Controlled Trials ◽

Inhaled Corticosteroid ◽

Long Acting ◽

Randomised Controlled

Download Full-text